Our 24/7 cancer helpline provides information and answers for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Our highly trained specialists are available 24/7 via phone and on weekdays can assist through video calls and online chat. We connect patients, caregivers, and family members with essential services and resources at every step of their cancer journey. Ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
This photo from ACS research grantee Andras Heczey, MD, shows a clear “win” from his phase 1 clinical trial of a new treatment for children who've been heavily treated for neuroblastoma.
This photo shows a clear “win” from a phase 1 clinical trial of a new treatment for children who have already been heavily treated for neuroblastoma. The photo was published in a study in Nature Medicine with co-authors and American Cancer Society (ACS) research grantees Andras Heczey, MD, and Leonid Metelitsa, MD, PhD.
We’ve followed these studies at Baylor College of Medicine since Heczey received his first ACS research grant in 2016. That’s when he was genetically adapting CAR T-Cell therapy to treat neuroblastoma. Later, on a TheoryLab podcast, Heczey talked about his work with neuroblastoma (and with pediatric liver cancer). And, we reported on his progress when he initiated his experimental treatment’s first clinical trial.
These images are from updated interim phase 1 trial results published in Nature Medicine. At this phase, anti-tumor activity wasn’t the first goal, so it’s much too early to deem this new treatment a success. What researchers did conclude was: